Marco Riboldi received his Master degree in Biomedical Engineering from Politecnico di Milano (2002), and obtained a PhD degree in Bioengineering in 2006 from the same Institution, with a project focused on Target Registration Error (TRE) analysis in external beam radiotherapy. He was appointed Roberto Rocca fellow in 2007 for a post-doc position at the Nuclear Science and Engineering Department of the Massachusetts Institute of Technology (Cambridge, MA). He concurrently obtained a Research Fellowship at Massachusetts General Hospital – Harvard Medical School (Boston, MA).
He contributed to clinical commissioning, research and development activities in the Bioengineering Unit at CNAO (Centro Nazionale di Adroterapia Oncologica) in Pavia, the first Italian national center for oncological particle therapy treatments, from 2008 till the end of 2016. In 2011 he was appointed Assistant Professor in Bioengineering, Politecnico di Milano. He is currently on a leave, serving as tenure track Associate Professor in Experimental Oncological Imaging, at the prestigious Physics Faculty of Ludwig-Maximilians Universität, Munich.
His research interests mainly comprise image guided therapy, computer aided radiosurgery and particle therapy. The main focus is the development and clinical application of biomedical technologies, methods and algorithms for time resolved image guided treatments in high precision radiation and particle therapy.